Jci_page_head_homepage_01 Jci_page_head_homepage_02
Song Li, Benjamin P.C. Chen, Nobuyoshi Azuma, Ying-Li Hu, Steven Z. Wu, Bauer E. Sumpio, John Y.-J. Shyy, Shu Chien
Published in Volume 103, Issue 8
J Clin Invest. 1999; 103(8):1141–1150 doi:10.1172/JCI5367
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 4

Cdc42, but not RhoA, is sufficient for JNK activation. HA-JNK1 (1 μg/slide) was cotransfected with pcDNA3, myc-RhoA(V14), myc-Cdc42(V12), Ras(V12), myc-Cdc42(V12) together with Ras(N17), or Ras(V12) together with HA-Cdc42(N17) (2 μg/slide for each). The total amount of the transfected plasmid DNA in the various samples was kept constant by supplementing with pcDNA3. About 40 h after transfection, the cells were lysed and kinase assay was performed on HA-JNK1. The bar graphs, representing mean ± SD from three separate experiments, show the JNK kinase activity of the various samples relative to that in the pcDNA3-transfected controls. Asterisks indicate significant difference (P < 0.05) compared with pcDNA3-transfected cells. Ras(N17) or HA-Cdc42(N17) have no inhibitory effects on JNK activity induced by myc-Cdc42(V12) or Ras(V12). Shown at bottom is the immunoblotting, indicating that similar levels of HA-JNK1 were expressed in various samples.